Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences

被引:31
|
作者
Kostyunin, Alexander [1 ]
Mukhamadiyarov, Rinat [1 ]
Glushkova, Tatiana [1 ]
Bogdanov, Leo [1 ]
Shishkova, Daria [1 ]
Osyaev, Nikolay [1 ]
Ovcharenko, Evgeniy [1 ]
Kutikhin, Anton [1 ]
机构
[1] Res Inst Complex Issues Cardiovasc Dis, Dept Expt Med, 6 Sosnovy Blvd, Kemerovo 650002, Russia
关键词
atherosclerosis; calcific aortic valve disease; calcific aortic stenosis; bioprosthetic heart valves; structural valve deterioration; structural valve degeneration; calcification; inflammation; neovascularisation; electron microscopy; EXTRACELLULAR-MATRIX; CARDIOVASCULAR CALCIFICATION; CIRCULATING BIOMARKERS; FASTER DEGENERATION; PLAQUE RUPTURE; RISK-FACTORS; TISSUE; INFLAMMATION; TRANSCATHETER; ANGIOGENESIS;
D O I
10.3390/ijms21207434
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atherosclerosis, calcific aortic valve disease (CAVD), and bioprosthetic heart valve degeneration (alternatively termed structural valve deterioration, SVD) represent three diseases affecting distinct components of the circulatory system and their substitutes, yet sharing multiple risk factors and commonly leading to the extraskeletal calcification. Whereas the histopathology of the mentioned disorders is well-described, their ultrastructural pathology is largely obscure due to the lack of appropriate investigation techniques. Employing an original method for sample preparation and the electron microscopy visualisation of calcified cardiovascular tissues, here we revisited the ultrastructural features of lipid retention, macrophage infiltration, intraplaque/intraleaflet haemorrhage, and calcification which are common or unique for the indicated types of cardiovascular disease. Atherosclerotic plaques were notable for the massive accumulation of lipids in the extracellular matrix (ECM), abundant macrophage content, and pronounced neovascularisation associated with blood leakage and calcium deposition. In contrast, CAVD and SVD generally did not require vasculo- or angiogenesis to occur, instead relying on fatigue-induced ECM degradation and the concurrent migration of immune cells. Unlike native tissues, bioprosthetic heart valves contained numerous specialised macrophages and were not capable of the regeneration that underscores ECM integrity as a pivotal factor for SVD prevention. While atherosclerosis, CAVD, and SVD show similar pathogenesis patterns, these disorders demonstrate considerable ultrastructural differences.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [21] Advancements in calcific aortic valve disease
    Carbone, Roberto G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 358 : 85 - 86
  • [22] BIOPROSTHETIC HEART-VALVE FAILURE - PATHOGENESIS OF CALCIFIC DEPOSITS
    SCHOEN, FJ
    LEVY, RJ
    NELSON, AC
    BERNHARD, WF
    NASHEF, A
    HAWLEY, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (02) : 601 - 601
  • [23] Biomarkers of Calcific Aortic Valve Disease
    Small, Aeron
    Kiss, Daniel
    Giri, Jay
    Anwaruddin, Saif
    Siddiqi, Hasan
    Guerraty, Marie
    Chirinos, Julio A.
    Ferrari, Giovanni
    Rader, Daniel J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (04) : 623 - 632
  • [24] Calcific Aortic Valve Disease and Hypertension
    Dadlani, Harsha
    Osman, Narin
    Ballinger, Mandy L.
    Marasco, Silvana
    Little, Peter J.
    CURRENT HYPERTENSION REVIEWS, 2008, 4 (02) : 107 - 113
  • [25] Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration
    Farina, Juan M.
    Chao, Chieh-Ju
    Pereyra, Milagros
    Roarke, Michael
    Said, Ebram F.
    Barry, Timothy
    Alsidawi, Said
    Sell-Dottin, Kristen
    Sweeney, John P.
    Fortuin, David F.
    Ayoub, Chadi
    Lester, Steven J.
    Oh, Jae K.
    Arsanjani, Reza
    Marcotte, Francois
    HEART, 2024, 110 (04) : 299 - 305
  • [26] Hypercholesterolemia is a Risk Factor for Aortic Bioprosthetic Valve Degeneration
    Mahjoub, Haifa
    Mathieu, Patrick
    Senechal, Mario
    Larose, Eric
    Dumesnil, Jean-Gaston
    Despres, Jean-Pierre
    Pibarot, Philippe
    CIRCULATION, 2011, 124 (21)
  • [27] Bioprosthetic valve thrombosis and degeneration following transcatheter aortic valve implantation (TAVI)
    Mirsadraee, S.
    Sellers, S.
    Duncan, A.
    Hamadanchi, A.
    Gorog, D. A.
    CLINICAL RADIOLOGY, 2021, 76 (01) : 73.e39 - 73.e47
  • [28] Effect of statins on the progression of bioprosthetic aortic valve degeneration
    Antonini-Canterin, F
    Zuppiroli, A
    Popescu, BA
    Granata, G
    Cervesato, E
    Piazza, R
    Pavan, D
    Nicolosi, GL
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (12): : 1479 - 1482
  • [29] Functional differences in human aortic valve interstitial cells from patients with varying calcific aortic valve disease
    Tuscher, Robin
    Khang, Alex
    West, Toni M.
    Camillo, Chiara
    Ferrari, Giovanni
    Sacks, Michael S.
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [30] Calcific Aortic Valve Disease: Cellular Origins of Valve Calcification
    Rajamannan, Nalini M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (12) : 2777 - 2778